development
-
Extremities
In2Bones USA and Invibio Announce R&D, Development and Manufacturing Agreement
Carbon-reinforced PEEK-OPTIMA™ biomaterial to enhance implant performance November 17, 2020 MEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc., a leading global manufacturer of…
Read More » -
Biologics
Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy
November 16, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior…
Read More » -
Biologics
SINTX Technologies Appoints Michael Marcroft As Vice President Of Business Development
SALT LAKE CITY, Oct. 05, 2020 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (www.SINTX.com) (NASDAQ: SINT), an original equipment manufacturer (OEM)…
Read More » -
Spine
Surgalign Names Douglas S. Bireley, Executive Vice President, Marketing and Research & Development
DEERFIELD, Ill., Aug. 17, 2020 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused…
Read More » -
Robotics
Titan Medical Establishes U.S. Subsidiary to Strengthen its Research and Product Development Activities
June 15, 2020 TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused…
Read More » -
Financial
Titan Medical Announces Development and License Agreements With Medtronic and Senior Secured Loan
June 4, 2020 TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (“Titan” or “Titan Medical”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused…
Read More » -
Spine
Implanet steps up development in Germany and consolidates its organization
March 03, 2020 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings…
Read More » -
Spine
Spineway USA Launches “Avenu” Podcast Series
Discussions Focused on Providing Insight to Maximize Growth and Productivity The Med Tech environment is always changing! Spineway USA, Inc.,…
Read More » -
Biologics
The American Academy of Orthopaedic Surgeons Makes Strategic Investment in Biologics Research and Development
ROSEMONT, Ill., Nov. 20, 2019 /PRNewswire/ — Today the American Academy of Orthopaedic Surgeons (AAOS) announced a strategic investment in the field of…
Read More » -
Financial
Conformis and Stryker Execute Development, License and Distribution Agreements
BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary…
Read More » -
OSN Premium
Shifts in Trauma: Insights From a 30-Year Veteran
by Elizabeth Hofheinz, M.P.H., M.Ed., September 3, 2019 Roy Sanders, M.D. is an established editor, academician, clinician, administrator and teac...…
Read More » -
Financial
Stryker only needs state approval for Portage brownfield plan
By Malachi Barrett – February 22, 2017 KALAMAZOO, MI — One final step remains to approve a brownfield plan for a…
Read More » -
Robotics
TransEnterix Opens Robotic Training and Research & Development Center in Milan
December 15, 2016 RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the…
Read More » -
Spine
William Rhoda Joins SeaSpine as General Manager of Process Innovation and Development
CARLSBAD, Calif., Dec. 08, 2016 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical…
Read More » -
Financial
TissueGene Licensee, Kolon Life Science, Partners With Mitsubishi Tanabe Pharma To Develop And Commercialize Invossa™, The World’s First Cell-Mediated Gene Therapy For Degenerative Osteoarthritis
ROCKVILLE, Md., Nov. 1, 2016 /PRNewswire/ — TissueGene, Inc. (TGI), a Maryland-based regenerative medicine company, today announced an exclusive licensing and development agreement between…
Read More »